At a panel at virtually hosted CERAWeek, energy innovation stakeholders discussed the future of cleantech. Photo via Getty Images

The energy technology and innovation ecosystem is comprised of stakeholders across the industry — from the academic institutions that house researchers in the field and the entrepreneurs with the big ideas to the venture backers who fund the scaling of these ideas and the corporations who put these new technologies into their supply chain.

A recent panel at CERAWeek by IHS Markit explored where the energy tech ecosystem is headed — and what all needs to be done to advance innovation. Missed the discussion or just want a refresher on on the highlights? Here are some significant overheard moments from the virtual panel.

“We need more energy innovation, and when we think about the energy system of the future there are key areas where we need more technology developed. We all need to encourage and support that early innovation.”

— Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures. Burger mentions that it's about collaboration. "All of us play a role in a critical part of the development."

“Not only do we have to have the innovation pipeline, but then we’ve got to really move quickly to work with governments, corporations, public-private partnerships that can be formed around these technologies.”

— Ashley Grosh, vice president of Breakthrough Energy. Grosh echoes the need for collaborative efforts. No one part of the equation — such as corporates, scientists, academics, etc. — can move the needle by itself.

“We face a need to run the current energy system extremely well … while also envisioning a new energy system.”

— Burger says. Burger, who alludes to the state's recent power grid failure as an example, says this balancing act is a challenge across the board for energy companies.

“Government is going to have to play aggressively to solve the climate problem.”

— Ilan Gur, CEO of Activate Global Inc., a nonprofit organization that WORKS with U.S.-based funders and research institutions to support a group of fellows. Gur says there needs to be some aspect of incentivization somewhere in the innovation process to drive results.

“Where the market works, let it work. And where it needs help, let’s double down.”

— Burger says, adding that it will take the public, corporations, innovators, and capital to make a difference. "If you can align those all toward derisking then scaling that technology, we will all benefit from the fruits of that labor.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.